Literature DB >> 16490612

Nosocomial pneumonia: state of the science.

Scott A Flanders1, Harold R Collard, Sanjay Saint.   

Abstract

Nosocomial pneumonia is the leading cause of mortality due to hospital-acquired infections. A thorough understanding of the most recent developments in evaluating and managing nosocomial pneumonia is critical for infection control professionals and hospital epidemiologists, given the incidence and cost of this important patient safety problem. We review the evidence on pathogenesis, diagnosis, treatment, and prevention of both ventilator-associated and nonventilator-associated pneumonia. Key recommendations are then provided for diagnostic testing strategies, antibiotic selection, and treatment duration. We also summarize the most recent data on how to prevent hospital-acquired infection, in general, and nosocomial pneumonia, in particular.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16490612     DOI: 10.1016/j.ajic.2005.07.003

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  18 in total

1.  Partial Depletion of Regulatory T Cells Enhances Host Inflammatory Response Against Acute Pseudomonas aeruginosa Infection After Sepsis.

Authors:  Zhi-Qiang Hu; Yong-Ming Yao; Wei Chen; Jia-Lan Bian; Lin-Jun Zhao; Long-Wang Chen; Guang-Liang Hong; Zhong-Qiu Lu; Guang-Ju Zhao
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

2.  Early bronchoalveolar lavage for intubated trauma patients with TBI or chest trauma.

Authors:  Tyler J Loftus; Stephen J Lemon; Linda L Nguyen; Stacy A Voils; Scott C Brakenridge; Janeen R Jordan; Chasen A Croft; R Stephen Smith; Frederick A Moore; Philip A Efron; Alicia M Mohr
Journal:  J Crit Care       Date:  2017-02-12       Impact factor: 3.425

Review 3.  Inhaled therapeutics for prevention and treatment of pneumonia.

Authors:  Amar Safdar; Samuel A Shelburne; Scott E Evans; Burton F Dickey
Journal:  Expert Opin Drug Saf       Date:  2009-07       Impact factor: 4.250

4.  Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi.

Authors:  Scott E Evans; Brenton L Scott; Cecilia G Clement; Derek T Larson; Dimitrios Kontoyiannis; Russell E Lewis; P Rocco Lasala; Jennifer Pawlik; Johnny W Peterson; Ashok K Chopra; Gary Klimpel; Gabriela Bowden; Magnus Höök; Yi Xu; Michael J Tuvim; Burton F Dickey
Journal:  Am J Respir Cell Mol Biol       Date:  2009-03-27       Impact factor: 6.914

Review 5.  Ventilator-associated pneumonia: problems with diagnosis and therapy.

Authors:  Jeanine P Wiener-Kronish; Henry Isaiah Dorr
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2008-09

6.  Inducible epithelial resistance protects mice against leukemia-associated pneumonia.

Authors:  Miguel M Leiva-Juárez; Hayden H Ware; Vikram V Kulkarni; Patrick A Zweidler-McKay; Michael J Tuvim; Scott E Evans
Journal:  Blood       Date:  2016-06-17       Impact factor: 22.113

7.  Characterization and modulation of the immunosuppressive phase of sepsis.

Authors:  Jared T Muenzer; Christopher G Davis; Kathy Chang; Robert E Schmidt; W Michael Dunne; Craig M Coopersmith; Richard S Hotchkiss
Journal:  Infect Immun       Date:  2010-01-25       Impact factor: 3.441

8.  Guideline-adherent initial intravenous antibiotic therapy for hospital-acquired/ventilator-associated pneumonia is clinically superior, saves lives and is cheaper than non guideline adherent therapy.

Authors:  Michael Wilke; R F Grube; K F Bodmann
Journal:  Eur J Med Res       Date:  2011-07-25       Impact factor: 2.175

9.  Evaluation of Synergistic Interactions Between Cell-Free Supernatant of Lactobacillus Strains and Amikacin and Genetamicin Against Pseudomonas aeruginosa.

Authors:  Sargol Aminnezhad; Rouha Kasra Kermanshahi; Reza Ranjbar
Journal:  Jundishapur J Microbiol       Date:  2015-04-18       Impact factor: 0.747

10.  Systemic inflammatory responses and lung injury following hip fracture surgery increases susceptibility to infection in aged rats.

Authors:  Hao Zhang; Tiansheng Sun; Zhi Liu; Jianzheng Zhang; Xiaowei Wang; Jia Liu
Journal:  Mediators Inflamm       Date:  2013-09-12       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.